One grounded in a mix of brutal honesty, real-world experience, and biochemistry
Long-term data shows that after 12 weeks, approximately 85% of users report mild or no nausea, while appetite control remains consistent
Comparing the two, tirzepatide sometimes brings more intense GI effects, especially at higher doses
41.1% retired, respectively)
Non-sweat ice pack in an insulated foam box, but the medication was loose and upside down in a small ziplock inside a larger ziplock that was not sealed, and two alcohol wipes were damp from the ice pack
Tirzepatide is a dual GIP/GLP-1 receptor agonist, a large peptide molecule weighing approximately 4,810 daltons